Skip to main content

Institutional intelligence for Rossari Biotech Ltd.

Cross-view mutual fund activity and super-investor shareholding · Jun 2026 SHP.

Ownership breakdown

Category totals from the official quarterly Shareholding Pattern filing (Jun 2026). Sums to 100.00%.

  • Promoters68.14%
  • FII2.02%
  • Mutual Funds9.77%
  • DII (ex-MF)4.87%
  • Retail & others15.20%
  • 1% Club 1.42%(subset)

Super Investors and 1% Club names below are disclosed holders at or above 1%. They are subsets of the categories above, not additive. View filing

Holder details (≥1% disclosed names)

Promoters

Promoter & promoter group

68.14%7 named
HolderStakeSharesValue (₹ Cr)
29.10%1,61,18,820₹849.6 Cr
13.16%72,89,320₹384.2 Cr
9.23%51,10,000₹269.4 Cr
5.45%30,16,200₹159.0 Cr
4.51%25,00,330₹131.8 Cr
4.45%24,65,000₹129.9 Cr
1.81%10,02,630₹52.9 Cr

Retail & others

Holders below 1% disclosure threshold and public non-institutions

15.20%

SEBI requires naming only shareholders with ≥1% stake. The remaining 15.20% includes retail investors, small HNIs, employee trusts, and other holders below the disclosure threshold — aggregated in the official filing.

Mutual Funds

Domestic mutual funds & UTI

9.77%2 named
HolderStakeSharesValue (₹ Cr)
6.36%35,22,645₹185.7 Cr
1.90%10,53,531₹55.5 Cr

DII (other)

Insurance, banks, AIF, other domestic institutions

4.87%1 named
HolderStakeSharesValue (₹ Cr)
Tracked as LIC4.01%22,19,115₹117.0 Cr

1% Club — Individuals & others

Non-promoter ≥1% holders not matched to a curated profile

1.42%1 named
HolderStakeSharesValue (₹ Cr)
1.42%7,85,248₹41.4 Cr

FII / FPI

Foreign portfolio investors

2.02%No names

No named holders ≥1% in this bucket.

Super Investors

Curated tracked investor profiles

No names

No curated super investor holds ≥1% in the latest filing. See FII, DII, and mutual fund holders in the sections above.

Shareholding data sourced from NSE/BSE regulatory filings. Category chart uses official filing totals; named holder lists include every disclosed ≥1% position. Not investment advice. See our disclaimer and methodology.